Ghana becomes first country to approve Oxford malaria vaccine R21/Matrix-M
The sign-off is said to be the first time a major vaccine has been approved in an African country ahead of rich nations – and it could end up saving countless lives. Ghana has become the first country in the world to approve a new malaria vaccine developed by Oxford University. R21/Matrix-M was shown to be up to 80% effective in a trial involving 400 children in Burkina Faso, published in September. Malaria kills more than 600,000 people each year, most of them children in Africa, and the search for a vaccine…
Read More
